Longer-lived imaging agents could hasten Alzheimer's research

In the past few years, despite the best efforts of scientists and medical researchers, drug after drug designed to slow or stop the progression of Alzheimer's disease has failed in clinical trials. Some had no effect on the ...

Highly organized structures discovered in microbial communities

Bacteria usually live in mixed communities with many different kinds of bacteria present. But it's been largely unknown how these communities are organized, because the technology didn't exist to see how they are structured ...

Nanoparticles release drugs to reduce tooth decay

Therapeutic agents intended to reduce dental plaque and prevent tooth decay are often removed by saliva and the act of swallowing before they can take effect. But a team of researchers has developed a way to keep the drugs ...

The most complete review of the peptide behind Alzheimer's

The hope is to be able, one day, to fight the pathogenic action of the amyloid-beta protein, whose build-up is associated with Alzheimer's disease. In the meantime, scientists—including a group from the International School ...

page 6 from 10